Global Glucagon Market Growth 2025-2031

Global Glucagon Market Growth 2025-2031

The global Glucagon market size is predicted to grow from US$ 612 million in 2025 to US$ 884 million in 2031; it is expected to grow at a CAGR of 6.3% from 2025 to 2031.

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.

LP Information, Inc. (LPI) ' newest research report, the “Glucagon Industry Forecast” looks at past sales and reviews total world Glucagon sales in 2024, providing a comprehensive analysis by region and market sector of projected Glucagon sales for 2025 through 2031. With Glucagon sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glucagon industry.

This Insight Report provides a comprehensive analysis of the global Glucagon landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glucagon portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Glucagon market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glucagon and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glucagon.

This report presents a comprehensive overview, market shares, and growth opportunities of Glucagon market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Inject Glucagon
Nasal Glucagon

Segmentation by Application:
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Glucagon market?

What factors are driving Glucagon market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Glucagon market opportunities vary by end market size?

How does Glucagon break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver. Show more